Patriot Financial Group Insurance Agency’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-47
Closed -$2K 1422
2022
Q2
$2K Sell
47
-7
-13% -$363 ﹤0.01% 1787
2022
Q1
$4K Buy
54
+14
+35% +$1.25K ﹤0.01% 1700
2021
Q4
$6K Sell
40
-83
-67% -$14.3K ﹤0.01% 1658
2021
Q3
$25K Buy
123
+5
+4% +$1.1K ﹤0.01% 1116
2021
Q2
$25K Buy
118
+1
+0.9% +$183 ﹤0.01% 1092
2021
Q1
$21K Buy
117
+7
+6% +$1.4K ﹤0.01% 1064
2020
Q4
$12K Buy
110
+86
+358% +$9.14K ﹤0.01% 1163
2020
Q3
$3K Buy
+24
New +$2.92K ﹤0.01% 1381

Other funds holding NVAX

Patriot Financial Group Insurance Agency's NVAX Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Novavax (NVAX) in Q3 2022, closing a stake of 47 shares — an estimated $2K sold.

Patriot Financial Group Insurance Agency first reported a position in NVAX in Q3 2020 and held it in 8 quarters. The position peaked at $25K in Q3 2021. 254 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 47 Novavax shares in Q3 2022, an estimated $2K.
  • Patriot Financial Group Insurance Agency first reported a position in Novavax in Q3 2020 and held it in 8 quarters.
  • Patriot Financial Group Insurance Agency's Novavax position peaked at $25K in Q3 2021.
  • 254 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.